Chris Watson

Chris Watson is Reader at Queen's University Belfast's Wellcome Wolfson Institute for Experimental Medicine, leading translational research on cardiovascular biomarkers and diabetic complications. His work spans molecular diagnostics, cardiac proteomics, and global health innovation.

Research domains include:

• Biomarker discovery for heart failure subtypes
• Molecular mechanisms of diabetic cardiomyopathy
• Paediatric infection diagnostics using miRNA signatures

Recent publications demonstrate advanced techniques in proteomic profiling and miRNA analysis applied to cardiac pathology and paediatric sepsis diagnosis.

Co-directs the Global Health (gHealth) Research Group developing diagnostic solutions for resource-limited settings, with active projects in sub-Saharan Africa addressing cardiovascular disease management.